Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Functional Massage Versus Passive Mobilization After Total Knee Replacement

3 de novembro de 2026 atualizado por: Azienda Ospedaliera Universitaria Integrata Verona

Functional Recovery in the Acute Phase After Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Two Different Physiotherapy Protocols

This study compares two physiotherapy treatments to help adults recover movement after total knee replacement: functional massage and passive knee mobilization. The main question is whether functional massage helps patients bend their knee further by the time they leave the acute hospital ward.

Forty adults undergoing replacement of one knee or both knees during the same operation will be randomly assigned to one of two groups. One group will receive functional massage according to Olaf Evjenth, and the other will receive passive manual knee mobilization. Both groups will also receive the same standard rehabilitation and pain management.

The assigned treatment will be provided once daily, starting on the first day after surgery and continuing until hospital discharge. Each treatment will last 10 minutes per operated knee.

A clinician who does not know which treatment the patient received will assess knee movement. The study will also evaluate pain, functional mobility, patient-reported outcomes, and length of hospital stay.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

This is a single-center, randomized, parallel-group superiority trial comparing two manual physiotherapy approaches during the acute phase after total knee arthroplasty.

An independent researcher will generate the random allocation sequence. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes, opened after eligibility has been confirmed and written informed consent obtained.

The primary analysis will follow the intention-to-treat principle. Passive knee flexion at discharge will be compared between groups using analysis of covariance, with baseline knee flexion as a covariate. For participants undergoing simultaneous bilateral total knee arthroplasty, one knee will be randomly selected for the primary analysis. A sensitivity analysis using mixed-effects models will account for paired knee measurements. Exploratory analyses will compare treatment effects in participants undergoing unilateral and simultaneous bilateral surgery.

Discharge timing depends on the availability of a bed in an inpatient rehabilitation facility rather than on predefined functional recovery thresholds.

Tipo de estudo

Intervencional

Inscrição (Estimado)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Verona
      • Verona, Verona, Itália, 37126
        • Azienda Ospedaliera Universitaria Integrata Verona - U.O.C. Ortopedia, Ospedale Chirurgico Confortini
        • Contato:
        • Contato:
        • Investigador principal:
          • Simone Patuzzo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 79 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Male and female patients aged 18 to 79 years.
  • Scheduled for elective primary total knee arthroplasty, either unilateral or simultaneous bilateral.
  • Ability to understand the nature of the study and provide written informed consent.

Exclusion Criteria:

  • Revision total knee arthroplasty.
  • Age 80 years or older.
  • Severe comorbidities that could interfere with participation in the rehabilitation protocol or outcome assessment, including severe heart failure, severe chronic obstructive pulmonary disease, severe obesity with body mass index greater than 40 kg/m², or neurological conditions with significant motor deficits.
  • Cognitive deficits that prevent understanding and signing the informed consent or active participation in rehabilitation.
  • Total knee arthroplasty performed for non-degenerative causes, such as acute trauma or tumors.
  • Concomitant participation in another interventional clinical trial.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Functional Massage

Participants receive functional massage according to Olaf Evjenth once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

Functional massage of the anterior thigh with passive or active-assisted knee flexion, performed with the patient seated. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

Comparador Ativo: Passive Manual Mobilization

Participants receive passive manual knee mobilization once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

Passive manual knee flexion and extension in the sagittal plane, performed with the patient supine. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Knee Flexion
Prazo: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Passive knee flexion is measured in degrees using a standard goniometer, with the assessor moving the knee. Measurements are collected daily from postoperative day 1 until hospital discharge

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Pain Intensity
Prazo: At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Pain intensity is assessed using a Visual Analogue Scale and recorded on a 0-10 scale, with higher scores indicating greater pain. Measurements are collected at baseline and daily after each rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Each daily measurement is recorded separately.

At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
Timed Up and Go Test
Prazo: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Time in seconds required to stand up, walk 3 meters, turn, walk back, and sit down. The test is performed daily after the rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Shorter times indicate better functional mobility. Each daily measurement is recorded separately.

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
Length of Hospital Stay
Prazo: At discharge from the acute hospital ward, typically 5-7 days after surgery.

Number of days from admission to the acute hospital ward until discharge

At discharge from the acute hospital ward, typically 5-7 days after surgery.
Oxford Knee Score on Postoperative Day 1
Prazo: Postoperative day 1.

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

Postoperative day 1.
Oxford Knee Score at Hospital Discharge
Prazo: At discharge from the acute hospital ward, typically 5-7 days after surgery.

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

At discharge from the acute hospital ward, typically 5-7 days after surgery.
Oxford Knee Score at 1 Month
Prazo: 1 month after surgery

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

1 month after surgery
Oxford Knee Score at 3 Months
Prazo: 3 months after surgery

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

3 months after surgery
EQ-5D-5L Utility Index at day 1
Prazo: Postoperative day 1.

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life

Postoperative day 1.
EQ-5D-5L Utility Index at discharge
Prazo: At discharge from the acute hospital ward, typically 5-7 days after surgery.

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life.

At discharge from the acute hospital ward, typically 5-7 days after surgery.
EQ-5D-5L Utility Index at 1 Month
Prazo: 1 month after surgery

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

1 month after surgery
EQ-5D-5L Utility Index at 3 Months
Prazo: 3 months after surgery

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

3 months after surgery
EQ VAS on Postoperative Day 1
Prazo: On postoperative day 1.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

On postoperative day 1.
EQ VAS at Hospital Discharge
Prazo: At hospital discharge, typically 5-7 days after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

At hospital discharge, typically 5-7 days after surgery.
EQ VAS at 1 Month
Prazo: At 1 month after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.The assessment is administered by telephone

At 1 month after surgery.
EQ VAS at 3 Months
Prazo: At 3 months after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. The assessment is administered by telephone

At 3 months after surgery.

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Walking Distance During Assisted Ambulation
Prazo: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Distance walked during assisted ambulation, measured in meters and recorded daily after the rehabilitation session.

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Simone Patuzzo, Azienda Ospedaliera Universitaria Integrata Verona

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

24 de novembro de 2026

Conclusão Primária (Estimado)

1 de maio de 2028

Conclusão do estudo (Estimado)

1 de agosto de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

3 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

3 de novembro de 2026

Primeira postagem (Real)

9 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

9 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

3 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • TKA-PATUZZO-2025-01
  • 1000CET (Outro identificador: Comitato Etico Territoriale Area Sud-Ovest Veneto (CET-ASOV))

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .